Management of atopic dermatitis – A review
Keywords:
Atopic dermatitis, managementAbstract
Atopic dermatitis is a chronic relapsing and remitting disease, which afflicts mostly theyoung ones. The treatment of atopic dermatitis is very frustrating as no singletherapeutic modality is satisfactory. The first breakthrough in its management camewith the advent of topical steroids. We are still awaiting the next breakthrough. Muchresearch is being done in this regard and the pick of the lot is topical immunotherapy.It may well prove to be the find of the decade in the management of atopic dermatitis.This article summarizes the established as well as unconventional therapeuticmodalities which help the patients as well as which has evidence of successful use.References
Schultz Larsen F. Atopic
dermatitis: a genetic
epidemiologic study in a
population based twin sample. J
Am Acad Dermatol 1993; 28:
-23.
Williams H, Robertson C,
Stewart A et al. Worldwide
variations in the prevalence of
symptoms of atopic eczema in
the international study of asthma
and allergies in childhood. J
Allergy Clin Immunol 1999; 103:
-38.
Jenner N, Campbell J, Marks R.
Morbidity and cost of atopic
eczema in Australia. Australas J
Dermatol 2004; 45: 16-22.
Subramanyan K. Role of mild
cleansing in the management of
patient skin. Dermatol Ther
; 17 (Suppl 1): 26-34.
Loden M. Role of topical
emollients and moisturizers in the
treatment of dry skin barrier
disorders. Am J Clin Dermatol
; 4: 771-88.
Chamlin S, Kao J, Frieden I et al.
Ceramide-dominant barrier repair
lipids alleviate childhood atopic
dermatitis: Changes in barrier
function provide a sensitive
indicator of disease activity. J Am
Acad Dermatol 2002; 47: 198-
Klein PA, Richard AF. Clark
RAF. An evidence-based review
of the efficacy of antihistamines
in relieving pruritus in atopic
dermatitis. Arch Dermatol 1999;
: 1522-5.
Imaizumi A, Kawakami T,
Murakami F et al. Effective
treatment of pruritus in atopic
dermatitis using H1
antihistamines (secondgeneration
anti-histamines):
changes in blood histamine and
tryptase levels. J Dermatol Sci
; 33: 23-9.
Portnoy JM, Dinakar C. Review
of cetirizine hydrochloride for the
treatment of allergic disorders.
Expert Opin Pharmakother 2004;
: 125-35.
Shimizu T, Nishihara J,
Watanabe H et al. Cetirizine, an
H1 receptor antagonist,
suppresses the expression of
macrophage migration inhibitory
factor: its potential anti
inflammatory action. Clin Exp
Allergy 2004; 34: 103-9.
David JA. Topical corticosteroids
in atopic dermatitis (editorial).
BMJ 2003; 327: 942-3.
Berth-Jones J, Damstra RJ,
Golsch S et al. Multinational
Study Group. Twice weekly
fluticasone propionate added to
emollient maintenance treatment
to reduce risk of relapse in atopic
dermatitis: randomized double blind, parallel group study. BMJ
; 326: 1367-9.
Tzaneva S, Seeber A, Schwaiger
N et al . High dose versus mediun
dose UVA -1 phototherapy for
patients with severe generalized
atopic dermatitis. J Am Acad
Dermatol 2001; 45: 503-7.
Abeck D, Schmidt T, Fesq H et
al. Long-term efficacy of
medium-dose UVA1
phototherapy in atopic dermatitis.
J Am Acad Dermatol 2000; 42:
-7.
Samson Yashar S, Gielczyk R,
Scherschum L, Liun HW.
Narrow band ultraviolet B
treatment for vitiligo, pruritus,
and inflammatory dermatosis.
Photodermatol Photoimmunol
Photomed 2003; 19: 164-8.
Grundmann-Kollmann M,
Behrens S, Podda M et al.
Phototherapy for atopic eczema
with narrow-band UVB. J Am
Acad Dermatol 1999; 40: 995-7.
Lubbe J. Secondary infections in
patients with atopic dermatitis.
Am J Clin Dermatol 2003; 4:
-54.
Zaki I, Enerson R, Allen BR.
Treatment of severe atopic
dermatitis in childhood with
cyclosporin. Br J Dermatol 1996;
(Suppl.48): 21-4.
Hakan G, Pekka E, Sakari R.
Long term follow up of eczema
patients treated with cyclosporin.
Acta Derm Venereologica 1998,
: 40-3.
Zouneveld M, De Rie MA,
Beljaards R et al. The long-term
safety and efficacy of cyclosporin
in severe refractory atopic
dermatitis: a comparison of two
dosage regimens. Br J Dermatol
; 135 (Suppl.48): 15-20.
Bornhovd E, Burgdorf W,
Wollenburg A. Macrolactum
immunomodulators for topical
treatment of inflammatory skin
diseases. J Am Acad Dermatol
; 45: 736-43.
Abramovits W, Goldstein AM,
Stevenson LC. Changing
paradigms in dermatology:
topical immunomodulators
within a per mutational paradigm
for the treatment of atopic and
eczematous dermatitis. Clin
Dermatol 2003; 21: 383-91.
Broshtilova V, Antonov D,
Bardarov E, Tsankov N. Severe
erythrodermic atopic dermatitis
treated with montelu kast.
Skinmed 2003; 2: 134-6.
Yanase D, David-Bajar K. The
leukotriene antagonist
montelukast as a therapeutic
agent for atopic dermatitis. J Am
Acad Dermatol 2001; 44: 89-93.
Rackal JM, Vender RB. The
treatment of atopic dermatitis and
other dermatoses with
leukotriene antagonists. Skin
Therapy Lett 2004; 9: 1-5.
Heike IR, Billman-Eberwein C,
Grewe M et al. Successful
monotherapy of severe and
intractable atopic dermatitis by
photopheresis. J Am Acad
Dermatol 1998; 38: 165-9.
Nikkels AF, Pierard GE. Framing
the future of antifungals in atopic
derma titis. Dermatology 2003;
: 398-400.
Matz H, Orion E, Wolf R.
Balneotherapy in dermatology.
Dermatol Ther 2003; 16: 132-40.
Mills L, Mordan L, Roth Het al.
Treatment of severe atopic
dermatitis by topical immune
modulation using
dinitrochlorobenzene. J Am Acad
Dermatol 2000; 42: 687-9.
Arkwright P, David T.
Intradermal administration of a
killed Mycobacterium vaccae
suspension (SRL 172) is
associated with improvement in
atopic dermatitis in children with
moderate-to-severe disease. J
Allergy Clin Immunol 2001; 107:
-4.
Alajbeg A, Vrzogic P,
Ostrogovic Z. Naphthalan--a
natural medicinal product. Acta
Dermatovenerol Croat 2003; 11:
-84.
Kalliomaki M, Salminen S,
Poussa T et al. Probiotics and
prevention of atopic disease: 4-
year follow-up of a randomized
placebo-controlled trial. Lancet
; 361: 1869-71.
Majamaa H, Isolauri E.
Probiotics: A novel approach in
the management of food allergy. J Allergy Clin Immunol 1997; 99:
-85.
Rosenfeldt V, Benfeldt E,
Nielsen SD et al. Effect of
probiotic Lactobacillus strains in
children with atopic dermatitis. J
Allergy Clin Immunol 2003; 111:
-95.
Stevens S, Hanifin J, Hamilton T
et al . Long-term effectiveness of
recombinant human interferon
gamma therapy for atopic
dermatitis despite unchanged
serum IgE levels. Arch Dermatol
; 134: 799-804.
Pickenäcker A, Luger T, Schwarz
T. Dyshidrotic eczema treated
with mycophenolate mofetil.
Arch Dermatol 1998; 134: 899.
Chen CJ, Yu HS. Acupuncture,
electrostimulation, and reflex
therapy in dermatology.
Dermatol Ther 2003; 16: 87-92.
Koo J, Desai R. Traditional
Chinese medicine in
dermatology. Dermatol Ther.
; 16: 98-105.
Koo J, Arian S. Traditional
Chinese Medicine for the
treatment of dermatologic
disorders. Arch Dermatol 1998;
: 1388-93.
Smolle J. Homeopathy in
dermatology. Dermatol Ther
; 16: 93-7.
Itamura R, Hosoya R.
Homeopathic treatment of
Japanese patients with intractable
atopic dermatitis. Homeopathy
; 92: 108-14.
Ricci G, Patrizi A, Bendandi B et
al. Clinical effectiveness of a silk
fabric in the treatment of atopic
dermatitis. Br J Dermatol 2004;
: 127-31.
Schempp CM, Windeck T, Hezel
S, Simon JC. Topical treatment
of atopic dermatitis with St.
John's wort cream-a randomized,
placebo controlled, double blind
half-side comparison.
Phytomedicine 2003; 10 (Suppl
: 31-7.
Shenefelt P. Hypnosis in
dermatology. Arch Dermatol
; 136: 393-9.
Uehara M, Su giura H, Sakurai K.
A trial of Oolong tea in the
management of recalcitrant
atopic dermatitis. Arch Dermatol
; 137: 42-3.
Al-Waili NS. Topic al application
of natural honey, beeswax and
olive oil mixture for atopic
dermatitis or psoriasis: partially
controlled, single-blinded study.
Complement Ther Med 2003; 11:
-34.
Shainhouse T, Eichenfield LF.
Long-term safety of tacrolimus
ointment in children treated for
atopic dermatitis. Expert Opin
Drug Saf 2003; 2: 457-65.
